Yujun Du

Dr. Yujun Du


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2014 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
YHYue Hou
Yue Hou
XLXiujiang Li
Xiujiang Li
LYLizhi Yang
Lizhi Yang
CLChang Liu
Chang Liu
HWHao Wu
Hao Wu
YDYujun Du
Yujun Du

1 November 2017 in Clinica Chimica Acta
Verified
Journal Article
Closed access
YHYue Hou
Yue Hou
XLXiujiang Li
Xiujiang Li
LSLiguang Sun
Liguang Sun
ZQZhihui Qu
Zhihui Qu
LJLili Jiang
Lili Jiang
YDYujun Du
Yujun Du

21 February 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
FYFan Yang
Fan Yang
LZLi Zhang
Li Zhang
HWHao Wu
Hao Wu
HZHongbin Zou
Hongbin Zou
YDYujun Du
Yujun Du
Acute kidney injury (AKI) is characterized by an abrupt decline in renal function, resulting in an inability to secrete waste products and maintain electrolyte and water balance, and is associated with high risks of morbidity and mortality. This study retrospectively analyzed clinical data, treatment, and prognosis of 271 hospitalized patients (172 males and 99 females) diagnosed with AKI from December, 2008 to December, 2011. In addition, this study explored the association between the cause of AKI and prognosis, severity and treatment of AKI. The severity of AKI was classified according to the Acute Kidney Injury Network (AKIN) criteria. Renal recovery was defined as a decrease in a serum creatinine level to the normal value. Prerenal, renal, and postrenal causes accounted for 36.5% (99 patients), 46.5% (126 patients) and 17.0% (46 patients), respectively, of the incidence of AKI. Conservative, surgical, and renal replacement treatments were given to 180 (66.4%), 30 (11.1%) and 61 patients (22.5%), respectively. The overall recovery rate was 21.0%, and the mortality rate was 19.6%. Levels of Cl−, Na+ and carbon dioxide combining power decreased with increasing severity of AKI. Cause and treatment were significantly associated with AKI prognosis. Likewise, the severity of AKI was significantly associated with cause, treatment and prognosis. Multivariate logistic regression analysis found that respiratory injury and multiple organ dysfunction syndrome (MODS) were associated with AKI patient death. Cause, treatment and AKIN stage are associated with the prognosis of AKI. Respiratory injury and MODS are prognostic factors for death of AKI patients.

6 May 2020 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
XWXuejiao Wei
Xuejiao Wei
XZXiaoyu Zhu
Xiaoyu Zhu
LJLili Jiang
Lili Jiang
XHXiu Huang
Xiu Huang
YZYangyang Zhang
Yangyang Zhang
YDYujun Du
Yujun Du

21 February 2020 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
YZYangyang Zhang
Yangyang Zhang
XZXiaoyu Zhu
Xiaoyu Zhu
XHXiu Huang
Xiu Huang
XWXuejiao Wei
Xuejiao Wei
DZDan Zhao
Dan Zhao
YDYujun Du
Yujun Du
Renal fibrosis is the common manifestation of the pathogenesis of end-stage renal disease that results from different types of renal insult, and is a hallmark of chronic kidney disease (CKD). The main pathologic characteristics of renal fibrosis are renal interstitial fibroblast hyperplasia and the aberrant and excessive deposition of extracellular matrix, pathologies that lead to the destruction of normal renal tubules and interstitial structures. However, the biological significance of fibrosis during the progression of CKD is not clear, and there are no approved clinical treatments for delaying or reversing renal fibrosis. Studies of the mechanism of renal fibrosis and of potential measures of prevention and treatment have focused on erythropoietin (EPO), a hormone best known as a regulator of red blood cell production. These recent studies have found that EPO may also provide efficient protection against renal fibrosis. Future therapeutic approaches using EPO offer new hope for patients with CKD. The aim of the present review is to briefly discuss the role of EPO in renal fibrosis, to identify its possible mechanisms in preventing renal fibrosis, and to provide novel ideas for the use of EPO in future treatments of renal fibrosis.

13 November 2014 in Molecular Medicine Reports
Verified
Journal Article
Open access
PDF file
LZLi-Rong Zhao
Li-Rong Zhao
YDYujun Du
Yujun Du
LCLei Chen
Lei Chen
Zhigang LiuZhigang Liu
Zhigang Liu
XJXiao-Yan Jia
Xiao-Yan Jia
BLBin Liu
Bin Liu
Omentin is a novel adipokine, which is expressed in and released from omental adipose tissue. In the present study, the effect of omentin on neural stem cells (NSCs) was investigated. NSCs are a subtype of stem cell in the nervous system, which are able to self‑renew and generate neurons and glia for repairing neural lesions. Mouse NSCs were isolated and cultured in vitro. Treatment with recombinant omentin for 3 and 5 days significantly increased the size of NSC neurospheres (P<0.01) and enhanced NSC cell viability in normal conditions. In addition, omentin protected against the decrease in cell viability induced by the pro‑inflammatory cytokine tumor necrosis factor‑α. In the NSCs, incubation of omentin for 2, 4, 6, 8 and 16 h enhanced the phosphorylation of Akt at the Thr308 site and of AS160 at the Ser318 site, peaking 6 h after treatment. Additionally, treatment with LY294002 (10 µM), a specific inhibitor of phosphatidylinositol 3‑kinase/Akt signaling, eliminated the omentin‑induced increase in neurosphere size and cell viability. Overall, the present study provided the first evidence, to the best of our knowledge, that omentin promotes the growth and survival of NSCs in vitro through activation of the Akt signaling pathway. These results may contribute to the understanding of the role of omentin in the nervous system.